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Introduction
Breast cancer screening has resulted in the detection of many
early cancers and the corresponding reduction in mortality
from the disease. However, population screening also results
in the detection and biopsy of many non-palpable breast
lesions that eventually prove to be benign, contributing to
increased health care costs and patient morbidity. The Breast
Imaging Reporting And Data System (BI-RADS), which was
created to standardize terminology and features in mammo-
graphic reporting, is widely used to stratify risk of malignancy,
thereby helping to select patients for biopsy. However, it has
been suggested that in Asian populations, where smaller breast
volumes result in relatively dense breasts on mammograms,
the sensitivity of mammograms is correspondingly lowered.1
Positive Predictive Value of BI-RADS Categorization in
an Asian Population
In this context, can BI-RADS categorization be as useful to us
as to our Western counterparts?
Needle-localization open biopsy (NLOB), the traditional
gold standard for biopsy of non-palpable breast lesions, has a
reported sensitivity of 96% to 99%.2 In recent years, with the
popularization of percutaneous breast biopsy devices, cou-
pled with image guidance and vacuum assistance, the role of
NLOB in the management of non-palpable breast lesions
needs to be redefined. Can we find a means to enable selection
of minimally invasive breast biopsy or NLOB in the manage-
ment of these lesions?
The aim of our study was to determine the incidence of
cancer following NLOB in patients with mammographically-
detected breast lesions and, hence, derive the positive predic-
tive value of BI-RADS in these patients. The role of BI-RADS
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categorization in the selection of appropriate breast biopsy
technique is also discussed.
Patients and methods
We retrospectively reviewed all patients who underwent mam-
mography followed by NLOB over a 6-year period from Janu-
ary 1995 to December 2000. All patients were managed in the
Department of General Surgery, Tan Tock Seng Hospital,
Singapore.
Mammography findings and reports were categorized
into BI-RADS 1 to 5 according to guidelines from the Ameri-
can College of Radiology. Mammograms without a BI-RADS
categorization were retrospectively read by an independent
radiologist trained in breast imaging and blinded to the final
histology.
Following mammography, selected patients underwent
breast sonography as an adjunct investigation at the clinical
discretion of the surgeon. This was usually due to discordance
between the clinical and mammographic findings. The deci-
sion for NLOB was made by the surgeon based on mammo-
graphic and/or sonographic findings, risk factors and the
desire of the patient.
Wire placement prior to open surgical biopsy was per-
formed under either mammographic or ultrasound guidance.
Following surgical biopsy, the removed breast tissue was
radiographed to confirm complete excision of the lesion. All
specimens were routinely processed and subjected to histo-
logical evaluation.
Histological reports were retrieved from the case notes.
Details including pathological findings and need for second
surgical procedures were recorded. Analysis of the data was
then carried out using standard statistical methods.
Results
Over a period of 6 years, we performed a total of 470 NLOB
procedures in 427 female patients. The mean age of the study
cohort was 49.7 years, with a range of 31 to 85 years. Most
patients (85%) were Chinese, which corresponded to local
population demographics.3
Of these patients, 72.1% were asymptomatic, with nearly
39% of the lesions picked up by screening. A further 30% of
lesions were diagnosed during surveillance of women on
hormone replacement therapy. Less than one-third (27.9%)
of patients had breast symptoms, most commonly a self-
detected breast lump.
Table 1 shows the breakdown of the mammographic
findings. Microcalcifications alone (44.9%) and a mass lesion
(32.1%) were the most common lesions reported. The remain-
ing lesions included a mass with associated microcalcifications
(8.5%), asymmetrical density (5.7%), and architectural distor-
tion (1.9%). Thirty-two patients (6.8%) had mammograms that
were reported as normal. Breast ultrasound in this group of
patients was performed at the discretion of the consulting
surgeon and/or due to discordant clinical and mammographic
findings. They subsequently underwent open biopsy of the
sonographically-detected lesions, which included complex
cystic lesions (3), solid nodules with regular margins (23) and
solid ill-defined nodules (6). The indications for biopsy were
similarly based on clinical suspicion, risk profile and the desire
of the patient, clearly demonstrating that mammography was
only one aspect in the consideration for biopsy.
Of 470 open biopsies, 393 (84%) showed benign histology.
Of the 77 (16%) malignant lesions, about one-third were inva-
sive cancers, with the rest being made up mainly of pre-invasive
cancers of the ductal type (Tables 2 and 3). While most cancers
presenting as clustered microcalcifications were eventually
determined to be carcinoma in situ (41/50), mass lesions with
or without associated microcalcifications were more likely to
have an infiltrative component (18/23) on histology.
The distribution of BI-RADS categorization is shown in
Table 4. Most lesions were categorized as BI-RADS 3 (42.8%)
and 4 (38.3%). Among the 32 (6.8%) patients with BI-RADS 1
Table 1. Mammographic findings from 470 biopsies
Mammographic feature n (%) In situ cancers Infiltrative cancers
Microcalcifications 211 (44.9) 41 19
Mass 151 (32.1) 13 13
Mass and microcalcifications 140 (8.5)1 12 15
Asymmetrical density 127 (5.7)1 11 10
Architectural distortion 119 (1.9)1 11 11
Normal 1132 (6.8)11 11 10
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and the 38 (8.1%) with BI-RADS 2 lesions, one patient in each
group had cancer. The first patient had a vague lump in her
breast and mammography showed normal heterogeneously
dense breasts. Ultrasound, however, showed an irregular solid
nodule corresponding to the palpable lesion, and excision of
this nodule revealed a subcentimetre ductal carcinoma in situ
(DCIS). The second patient had a history of mastectomy for
breast cancer several years previously. This episode, she pre-
sented with bloody nipple discharge and a palpable lump on
the contralateral side. Mammogram revealed an apparently
benign asymmetric density in heterogeneously dense breasts,
and ultrasound showed a corresponding solid nodule with
well-defined margins. Biopsy was performed in view of the
history and presenting symptoms and the lesion turned out to
be DCIS.
Of all lesions, 4% were categorized as highly suspicious of
malignancy (BI-RADS 5). Further analysis indicated that the
positive predictive value of BI-RADS 5 for cancer was 0.84.
There were equal numbers of invasive and pre-invasive cancers
among the 16 malignant BI-RADS 5 lesions. All eight pre-
invasive cancers presented as clustered microcalcifications. Of
the eight invasive cancers, seven were associated with a mass
lesion on mammography, with only one lesion presenting as
microcalcifications only. The positive predictive value of BI-
RADS 4 for cancer was 0.27 (Table 4). Of the BI-RADS 4 lesions
that were malignant, twice as many were pre-invasive (33/49)
than invasive (16/49). Of 34 microcalcification-only lesions in
this category, 29 were pre-invasive cancers. Eight of 10 lesions
associated with a mass were invasive cancers. Among the 77
patients in the study cohort diagnosed with cancer, 76% re-
quired a second surgical procedure, either for further surgical
margins and/or axillary clearance.
Discussion
Our results indicate that BI-RADS categorization remains a
useful tool to stratify risk of malignancy in a female popula-
tion with increased breast density such as ours. The overall
cancer incidence in our study population was 16%, which is
comparable to figures from other reported series, which range
from 20% to 53%.4–10 There was one cancer each among
patients whose mammograms were categorized as BI-RADS
1 and 2 (3.1% and 2.6%, respectively). Both these patients
had solid nodules on ultrasound and underwent open bi-
opsy. While the number of subjects with BI-RADS 1 and 2
were small, these findings may be in keeping with the de-
creased sensitivity of mammograms in patients with dense
breasts.
Among the 180 patients whose mammograms were
categorized as BI-RADS 4, 49 had cancer, giving a positive
predictive value of 0.27. The corresponding positive predictive
value of BI-RADS 5 lesions was 0.84 (16/19). These figures are
similar to those reported by Liberman et al (0.34 and 0.81 for
Table 2. Benign pathology (n = 393)
Benign pathology n (%)
Fibrocystic change 245 (62.3)
Fibroadenoma 108 (27.5)
Ductal hyperplasia 151 (13.0)
ADH 19 (4.8)
Sclerosing adenosis 18 (4.6)
Papilloma 15 (3.8)
Radial scar 10 (2.5)
ALH 15 (1.3)
Others* 164 (16.3)
*These include stromal fibrosis, fibroadenosis, fibroadenomatoid
hyperplasia, ductal ectasia, involutional change, apocrine metapla-
sia and foreign body granuloma. ADH = atypical ductal hyperplasia;
ALH = atypical lobular hyperplasia.
Table 3. Malignant pathology (n = 77)
Pathology n (%)
DCIS 45 (58.4)
IDC 25 (32.5)
LCIS 4 (5.2)
ILC 3 (3.9)
DCIS = ductal carcinoma in situ; IDC = infiltrative ductal carcinoma;
LCIS = lobular carcinoma in situ; ILC = infiltrative lobular carcinoma.
Table 4. Breast Imaging Reporting And Data System (BI-RADS) categorization of 470 biopsies
BI-RADS n (%) Cancers Positive predictive value (%) Negative predictive value (%)
1 32 (6.8) 11 – 96.9
2 38 (8.1) 11 – 97.4
3 201 (42.8) 10 – 95.0
4 180 (38.3) 49 27.2 –
5 19 (4.0) 16 84.2 –
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BI-RADS 4 and 5, respectively)11 and other investigators.5,12
We think that BI-RADS categorization may help us to
select between percutaneous or open surgical methods for
biopsy of non-palpable breast lesions. Percutaneous methods
are recommended for most image-detected lesions.13 Percuta-
neous breast biopsy is relatively simple to perform and obvi-
ates the need for localization by pre-biopsy wire placement. It
is conducted in an outpatient setting under local anaesthesia,
and is cosmetically more acceptable. Lee et al demonstrated
that stereotactic 14G automated core biopsy obviated the
need for open surgery in 81% of lesions.14
Most of the controversy lies in the ideal modality for the
initial evaluation of highly suspicious BI-RADS 5 lesions. Yim
et al reported that initial stereotactic core needle biopsy (SCNB)
for suspicious lesions enables a planned surgical strategy
resulting in a single operative procedure for the patient.15
Morrow et al, in their study of 1,852 mammographically-
detected abnormalities, found that lesions thought to be dif-
fuse or requiring axillary surgery may be better evaluated
initially with SCNB.16 On the other hand, Johnson et al re-
ported that, in highly suspicious calcifications without associ-
ated parenchymal abnormality, surgical biopsy performed as
a formal lumpectomy enables diagnosis and therapy at a single
sitting.17 Frazee et al reported no difference between open and
stereotactic biopsies with regard to diagnostic accuracy, com-
plications and patient satisfaction, although cost was de-
creased in the group who underwent stereotactic biopsy in his
study.18 However, Fahy et al found no overall difference in
cost-benefit for BI-RADS 5 lesions evaluated initially with
SCNB or NLOB.19
Besides merely looking at BI-RADS categorization, we
suggest that for BI-RADS 5 lesions, the nature of the specific
mammographic abnormality may give a clue as to the likely
pathology and, hence, guide the decision-making process.
Masses categorized as BI-RADS 5, which are usually inva-
sive carcinomas, should be distinguished from BI-RADS 5
calcifications, which are more likely to be DCIS. This is re-
flected in our study population, where among the 16 BI-RADS
5 cancers, eight of nine microcalcification-only lesions seen on
mammography were in situ carcinomas, while all seven mass
lesions were invasive carcinomas. Similarly, among the 49 BI-
RADS 4 cancers, 29 of 34 microcalcification-only lesions were
in situ cancers, and eight of 10 lesions associated with a mass
were invasive cancers. Lee et al found that, while SCNB obvi-
ated one surgical biopsy in most patients with highly suspi-
cious lesions, this difference was more marked for highly
suspicious masses than for highly suspicious calcifications.14
Similarly, Liberman et al also reported that SCNB obviated a
surgical biopsy in 77% of BI-RADS 5 masses versus 42% of BI-
RADS 5 calcifications.20 This suggests that, for BI-RADS 5
clustered calcifications, initial management with NLOB as a
formal lumpectomy may be more appropriate as a single-stage
surgical procedure, serving both a diagnostic and therapeutic
role. This would obviate the need for preoperative tissue diag-
nosis by SCNB. For BI-RADS 5 lesions associated with a mass,
an initial biopsy by SCNB to confirm the nature of the malig-
nancy will be more useful to facilitate development of an
appropriate surgical strategy that may include determination
of the axillary status as necessary.
We conclude that, in spite of mammographically-dense
breasts, BI-RADS categorization is still a useful predictor of
malignancy in our Asian population. In lesions categorized as
BI-RADS 4 or less, where the cancer incidence is less than 30%,
percutaneous image-guided breast biopsy should be consid-
ered as the diagnostic modality of choice where histology is
desired. With this approach, the patient benefits from less
morbidity, improved cosmesis and a better overall experience
by avoiding an unnecessary surgical procedure. Where the
likelihood of cancer is high, as in BI-RADS 5 lesions, the
specific mammographic feature should be taken into account
in the decision-making process. For mass lesions, where an
invasive component is likely, initial evaluation with SCNB
may facilitate surgical planning, with a strategy for wide exci-
sion or mastectomy with sentinel lymph node biopsy and
axillary clearance as a single procedure, should the histology
on core biopsy show invasive carcinoma. If carcinoma in situ is
the likely diagnosis based on clustered calcifications on the
mammogram, NLOB performed as a formal lumpectomy may
reduce the need for a second surgical procedure. On the other
hand, if the BI-RADS 5 calcifications are non-clustered and
dispersed over a large area, SCNB may be performed, as a
mastectomy may eventually be required due to the diffuse
nature of the disease. An algorithm for biopsy choice is sug-
gested based on the BI-RADS categorization (Figure). However,
further studies would be required to validate these recommen-
dations in our local Asian population.
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